Sign in to view content

Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema

Chirag D. Jhaveri, MD, FASRS

Video
Published 2022

Related

Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
Dual Targeting VEGF/Ang3 Surrobody in an Experimental Model of Neovascularization
Jeffrey L. Olson, MD
Annual Meeting Talks
2019
Retinal Detachment Rates after Intravitreal Anti-VEGF Injections- Dr. Omesh Gupta
Keyvan Koushan, MD, FRCSC
Member Podcasts
2020

Category: Diabetic Macular Edema

See more